Page last updated: 2024-10-25

ciprofloxacin and Insulin Sensitivity

ciprofloxacin has been researched along with Insulin Sensitivity in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"Twelve non-alcoholic steatohepatitis patients and 11 controls were studied before and after ciprofloxacin 500 mg b."2.71Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. ( Jones, R; Mottershead, M; Nwokolo, CU; Sajjad, A; Smith, S; Syn, WK, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sajjad, A1
Mottershead, M1
Syn, WK1
Jones, R1
Smith, S1
Nwokolo, CU1

Trials

1 trial available for ciprofloxacin and Insulin Sensitivity

ArticleYear
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis.
    Alimentary pharmacology & therapeutics, 2005, Aug-15, Volume: 22, Issue:4

    Topics: Adult; Aged; Anti-Infective Agents; Blood Glucose; Ciprofloxacin; Ethanol; Fatty Liver; Ghrelin; Hum

2005